Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent
- PMID: 12223355
- DOI: 10.1152/ajpgi.00151.2002
Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent
Abstract
Cathepsin B (Cat B) is released from lysososomes during tumor necrosis factor-alpha (TNF-alpha) cytotoxic signaling in hepatocytes and contributes to cell death. Sphingosine has recently been implicated in lysosomal permeabilization and is increased in the liver by TNF-alpha. Thus the aims of this study were to examine the mechanisms involved in TNF-alpha-associated lysosomal permeabilization, especially the role of sphingosine. Confocal microscopy demonstrated Cat B-green fluorescent protein and LysoTracker Red were both released from lysosomes after treatment of McNtcp.24 cells with TNF-alpha/actinomycin D, a finding compatible with lysosomal destabilization. In contrast, endosomes labeled with Texas Red dextran remained intact, suggesting lysosomes were specifically targeted for permeabilization. LysoTracker Red was released from lysosomes in hepatocytes treated with TNF-alpha or sphingosine in Cat B(+/+) but not Cat B(-/-) hepatocytes, as assessed by a fluorescence-based assay. With the use of a calcein release assay in isolated lysosomes, sphingosine permeabilized liver lysosomes isolated from Cat B(+/+) but not Cat B(-/-) liver. C(6) ceramide did not permeabilize lysosomes. In conclusion, these data implicate a sphingosine-Cat B interaction inducing lysosomal destabilization during TNF-alpha cytotoxic signaling.
Similar articles
-
TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent.Am J Physiol Gastrointest Liver Physiol. 2004 Aug;287(2):G436-43. doi: 10.1152/ajpgi.00019.2004. Epub 2004 Apr 8. Am J Physiol Gastrointest Liver Physiol. 2004. PMID: 15075251
-
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.Hepatology. 2004 Jul;40(1):185-94. doi: 10.1002/hep.20283. Hepatology. 2004. PMID: 15239102
-
Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis.Cancer Res. 2007 Dec 1;67(23):11176-85. doi: 10.1158/0008-5472.CAN-07-2333. Cancer Res. 2007. PMID: 18056442
-
Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L.Biol Chem. 2001 May;382(5):735-41. doi: 10.1515/BC.2001.089. Biol Chem. 2001. PMID: 11517926 Review.
-
CD107a (LAMP-1) and CD107b (LAMP-2).J Biol Regul Homeost Agents. 2002 Apr-Jun;16(2):147-51. J Biol Regul Homeost Agents. 2002. PMID: 12144129 Review. No abstract available.
Cited by
-
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses.Sci Transl Med. 2016 Sep 7;8(355):355ra118. doi: 10.1126/scitranslmed.aad9823. Sci Transl Med. 2016. PMID: 27605553 Free PMC article.
-
NF-kappaB protects from the lysosomal pathway of cell death.EMBO J. 2003 Oct 1;22(19):5313-22. doi: 10.1093/emboj/cdg510. EMBO J. 2003. PMID: 14517268 Free PMC article.
-
CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma.Cancer Immunol Immunother. 2023 Jun;72(6):1567-1580. doi: 10.1007/s00262-022-03344-9. Epub 2022 Dec 19. Cancer Immunol Immunother. 2023. PMID: 36534148 Free PMC article.
-
Endolysosomal proteases and their inhibitors in immunity.Nat Rev Immunol. 2009 Dec;9(12):871-82. doi: 10.1038/nri2671. Nat Rev Immunol. 2009. PMID: 19935806 Review.
-
Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease.Int J Mol Sci. 2020 May 29;21(11):3858. doi: 10.3390/ijms21113858. Int J Mol Sci. 2020. PMID: 32485811 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
